Biotechnology Wall Street Analysts Think Allogene Therapeutics (ALLO) Could Surge 159%: Read This Before Placing a Bet December 8, 2022
Biotechnology Down 5.9% in 4 Weeks, Here’s Why Galapagos NV (GLPG) Looks Ripe for a Turnaround December 8, 2022
Biotechnology Apellis Pharmaceuticals, Inc. (APLS) Down 0.5% Since Last Earnings Report: Can It Rebound? December 7, 2022
Biotechnology Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland December 7, 2022
Biotechnology Axsome Therapeutics Presents New Data from the EVOLVE Open-Label Trial Demonstrating Effects of AUVELITY® on Cognitive and Physical Functioning in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology (ACNP) 2022 Annual Meeting December 7, 2022